CoChat

Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle

Banerjee, Ayan, Phillips, Brittany L., Deng, Quidong, Seyfried, Nicholas T., Pavlath, Grace K., Vest, Katherine E., Corbett, Anita H. · 2019 · Journal of Biological Chemistry
Cited by 13

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.ra118.007287

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 87

  1. Amiel, 2004, Polyalanine expansions in human, Hum. Mol. Genet, 13, R235, 10.1093/hmg/ddh251 · DOI · Paper page
  2. Messaed, 2009, Molecular mechanisms underlying polyalanine diseases, Neurobiol. Dis, 34, 397, 10.1016/j.nbd.2009.02.013 · DOI
  3. Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
  4. Jouan, 2014, An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 41, 508, 10.1017/S0317167100018588 · DOI · Paper page
  5. Albrecht, 2005, The other trinucleotide repeat: polyalanine expansion disorders, Curr. Opin. Genet. Dev, 15, 285, 10.1016/j.gde.2005.04.003 · DOI · Paper page
  6. Uyama, 2000, Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy, Muscle Nerve, 23, 1549, 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0 · DOI
  7. Calado, 2000, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum. Mol. Genet, 9, 2321, 10.1093/oxfordjournals.hmg.a018924 · DOI · Paper page
  8. Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol. Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
  9. Mankodi, 2012, Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy, Neurobiol. Dis, 45, 539, 10.1016/j.nbd.2011.09.010 · DOI
  10. Dion, 2005, Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice, Neurobiol. Dis, 18, 528, 10.1016/j.nbd.2004.09.021 · DOI
  11. Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum. Mol. Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
  12. Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol. Cell. Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
  13. Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol. Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
  14. Fan, 2003, HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 30, 244, 10.1017/S0317167100002675 · DOI
  15. Apponi, 2013, Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle, Skeletal Muscle, 3, 23, 10.1186/2044-5040-3-23 · DOI · Paper page
  16. Phillips, 2018, Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR, Nucleic Acids Res, 46, 7643, 10.1093/nar/gky535 · DOI · Paper page
  17. Gerstberger, 2014, Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease, Adv. Exp. Med. Biol, 825, 1, 10.1007/978-1-4939-1221-6_1 · DOI · Paper page
  18. Banerjee, 2013, PABPN1: molecular function and muscle disease, FEBS J, 280, 4230, 10.1111/febs.12294 · DOI · Paper page
  19. Kühn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J. Biol. Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
  20. Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
  21. de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res, 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
  22. Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum. Mol. Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
  23. Calado, 2000, Deciphering the cellular pathway for transport of poly(A)-binding protein II, RNA, 6, 245, 10.1017/S1355838200991908 · DOI
  24. Ishigaki, 2001, Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20, Cell, 106, 607, 10.1016/S0092-8674(01)00475-5 · DOI · Paper page
  25. Abu-Baker, 2007, Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 · DOI
  26. Goodman, 1997, Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract, Proc. Natl. Acad. Sci. U.S.A, 94, 7458, 10.1073/pnas.94.14.7458 · DOI · Paper page
  27. Tavanez, 2009, Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1, PLoS One, 4, e6418, 10.1371/journal.pone.0006418 · DOI
  28. Kim, 2001, The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression, Hum. Mol. Genet, 10, 1129, 10.1093/hmg/10.11.1129 · DOI
  29. Banerjee, 2017, Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing, Nucleic Acids Res, 45, 10706, 10.1093/nar/gkx786 · DOI · Paper page
  30. Küsters, 2009, TDP-43 accumulation is common in myopathies with rimmed vacuoles, Acta Neuropathol, 117, 209, 10.1007/s00401-008-0471-2 · DOI · Paper page
  31. Chou, 2015, PABPN1 suppresses TDP-43 toxicity in ALS disease models, Hum. Mol. Genet, 24, 5154, 10.1093/hmg/ddv238 · DOI
  32. Vogler, 2018, TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle, Nature, 563, 508, 10.1038/s41586-018-0665-2 · DOI · Paper page
  33. Vest, 2017, Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology, Hum. Mol. Genet, 26, 3235, 10.1093/hmg/ddx206 · DOI · Paper page
  34. Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat. Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
  35. Randolph, 2014, Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner, J. Physiol, 592, 5301, 10.1113/jphysiol.2014.280420 · DOI · Paper page
  36. Vest, 2015, An antibody to detect alanine-expanded PABPN1: a new tool to study oculopharyngeal muscular dystrophy, J. Neuromuscul. Dis, 2, 439, 10.3233/JND-150111 · DOI · Paper page
  37. Kühn, 2003, The RNA binding domains of the nuclear poly(A)-binding protein, J. Biol. Chem, 278, 16916, 10.1074/jbc.M209886200 · DOI
  38. Kühn, 2004, Structure and function of poly(A) binding proteins, Biochim. Biophys. Acta, 1678, 67, 10.1016/j.bbaexp.2004.03.008 · DOI · Paper page
  39. Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 · DOI · Paper page
  40. Cykowski, 2018, Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis, Acta Neuropathol. Commun, 6, 28, 10.1186/s40478-018-0528-y · DOI
  41. Cortese, 2014, Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy, Neurobiol. Aging, 35, 1491, 10.1016/j.neurobiolaging.2013.12.029 · DOI
  42. Cutler, 2017, Biochemical isolation of myonuclei from mouse skeletal muscle tissue, Bio Protocol, 7, e2654, 10.21769/BioProtoc.2654 · doi:10.21769/bioprotoc.2654
  43. Chal, 2017, Making muscle: skeletal myogenesis in vivo and in vitro, Development, 144, 2104, 10.1242/dev.151035 · DOI · Paper page
  44. Cohen, 2012, Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking, EMBO J, 31, 1241, 10.1038/emboj.2011.471 · DOI · Paper page
  45. Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat. Neurosci, 14, 452, 10.1038/nn.2778 · DOI · Paper page
  46. Ricketts, 2014, A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects, PLoS One, 9, e85962, 10.1371/journal.pone.0085962 · DOI
  47. Afroz, 2017, Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation, Nat. Commun, 8, 45, 10.1038/s41467-017-00062-0 · DOI · Paper page
  48. Mohagheghi, 2016, TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor, Hum. Mol. Genet, 25, 534, 10.1093/hmg/ddv491 · DOI · Paper page
  49. Ariga, 2008, Functional role of sortilin in myogenesis and development of insulin-responsive glucose transport system in C2C12 myocytes, J. Biol. Chem, 283, 10208, 10.1074/jbc.M710604200 · DOI · Paper page
  50. Shi, 2005, Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes, Dev. Cell, 9, 99, 10.1016/j.devcel.2005.04.004 · DOI · Paper page
  51. Carrasquillo, 2010, Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma, Am. J. Hum. Genet, 87, 890, 10.1016/j.ajhg.2010.11.002 · DOI · Paper page
  52. Hu, 2010, Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin, Neuron, 68, 654, 10.1016/j.neuron.2010.09.034 · DOI · Paper page
  53. Holler, 2017, Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations, eNeuro, 4, 10.1523/ENEURO.0100-17.2017 · DOI · Paper page
  54. Zheng, 2011, C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking, PLoS One, 6, e21023, 10.1371/journal.pone.0021023 · DOI · Paper page
  55. Tavanez, 2005, In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1, RNA, 11, 752, 10.1261/rna.7217105 · DOI
  56. Raz, 2011, Reversible aggregation of PABPN1 pre-inclusion structures, Nucleus, 2, 208, 10.4161/nucl.2.3.15736 · DOI · Paper page
  57. Fronz, 2011, Arginine methylation of the nuclear poly(a) binding protein weakens the interaction with its nuclear import receptor, transportin, J. Biol. Chem, 286, 32986, 10.1074/jbc.M111.273912 · DOI
  58. Aktas, 2017, DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome, Nature, 544, 115, 10.1038/nature21715 · DOI · Paper page
  59. Moore, 2018, Csde1 binds transcripts involved in protein homeostasis and controls their expression in an erythroid cell line, Sci. Rep, 8, 2628, 10.1038/s41598-018-20518-7 · DOI
  60. Ma, 1997, The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA, Nucleic Acids Res, 25, 3564, 10.1093/nar/25.18.3564 · DOI · Paper page
  61. Medghalchi, 2001, Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability, Hum. Mol. Genet, 10, 99, 10.1093/hmg/10.2.99 · DOI · Paper page
  62. Kim, 2005, Mammalian Staufen1 recruits Upf1 to specific mRNA 3′UTRs so as to elicit mRNA decay, Cell, 120, 195, 10.1016/j.cell.2004.11.050 · DOI · Paper page
  63. Koh, 2014, Repetitive RNA unwinding by RNA helicase A facilitates RNA annealing, Nucleic Acids Res, 42, 8556, 10.1093/nar/gku523 · DOI
  64. Kamelgarn, 2016, Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS, Biochim. Biophys. Acta, 1862, 2004, 10.1016/j.bbadis.2016.07.015 · DOI · Paper page
  65. Chi, 2018, Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins, Sci. Rep, 8, 8755, 10.1038/s41598-018-27136-3 · DOI
  66. Pauzner, 1991, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Muscle Nerve, 14, 947, 10.1002/mus.880141004 · doi:10.1002/mus.880141004
  67. Chartier, 2015, Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis, PLoS Genet, 11, e1005092, 10.1371/journal.pgen.1005092 · DOI
  68. Franco-Iborra, 2018, Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson's disease and Huntington's disease, Front. Neurosci, 12, 342, 10.3389/fnins.2018.00342 · DOI · Paper page
  69. Toriumi, 2008, Expression of polyalanine stretches induces mitochondrial dysfunction, J. Neurosci. Res, 86, 1529, 10.1002/jnr.21619 · DOI
  70. Toriumi, 2009, Polyalanine tracts directly induce the release of cytochrome c, independently of the mitochondrial permeability transition pore, leading to apoptosis, Genes Cells, 14, 751, 10.1111/j.1365-2443.2009.01307.x · DOI
  71. Lopez-Gonzalez, 2016, Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons, Neuron, 92, 383, 10.1016/j.neuron.2016.09.015 · DOI · Paper page
  72. Wang, 2016, The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity, Nat. Med, 22, 869, 10.1038/nm.4130 · DOI · Paper page
  73. Davis, 2018, TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics, Neurosci. Lett, 678, 8, 10.1016/j.neulet.2018.04.053 · DOI · Paper page
  74. Ling, 2010, ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS, Proc. Natl. Acad. Sci. U.S.A, 107, 13318, 10.1073/pnas.1008227107 · DOI · Paper page
  75. Cohen, 2011, TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies, Trends Mol. Med, 17, 659, 10.1016/j.molmed.2011.06.004 · DOI · Paper page
  76. Kim, 2010, Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA, J. Biol. Chem, 285, 34097, 10.1074/jbc.M110.154831 · DOI · Paper page
  77. Johnson, 2014, Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis, Nat. Neurosci, 17, 664, 10.1038/nn.3688 · DOI · Paper page
  78. Tada, 2018, Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis, Am. J. Pathol, 188, 507, 10.1016/j.ajpath.2017.10.007 · DOI
  79. Weihl, 2008, TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia, J. Neurol. Neurosurg. Psychiatry, 79, 1186, 10.1136/jnnp.2007.131334 · DOI · Paper page
  80. Lei, 1999, The RAP74 subunit of human transcription factor IIF has similar roles in initiation and elongation, Mol. Cell. Biol, 19, 8372, 10.1128/MCB.19.12.8372 · DOI
  81. Renz, 1996, Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA, Nucleic Acids Res, 24, 843, 10.1093/nar/24.5.843 · DOI
  82. Dahl, 1998, The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42, Oncogene, 16, 1579, 10.1038/sj.onc.1201687 · DOI
  83. Figueroa, 2004, Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-β1 and bone morphogenetic protein-2 in C2C12 cells, Exp. Cell Res, 296, 163, 10.1016/j.yexcr.2004.01.025 · DOI
  84. Yamaguchi, 2016, FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription, Sci. Rep, 6, 35195, 10.1038/srep35195 · DOI
  85. Donovan, 2013, Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease, Alzheimers Res. Ther, 5, 32, 10.1186/alzrt186 · DOI · Paper page
  86. Zambon, 2012, GO-Elite: a flexible solution for pathway and ontology over-representation, Bioinformatics, 28, 2209, 10.1093/bioinformatics/bts366 · DOI · Paper page
  87. Wobst, 2017, Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant, PLoS One, 12, e0177181, 10.1371/journal.pone.0177181 · DOI

Metadata

Authors
Banerjee, A., Phillips, B. L., Deng, Q., Seyfried, N. T., Pavlath, G. K., Vest, K. E., & Corbett, A. H.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2019-05
Volume
294
Issue
18
Pages
7360-7376
ISSN
0021-9258
Cited by
13
References
3
Language
en
Licence
Funders
  • HHS | National Institutes of Health (5RO1AR061987, 5F32AR068207)
  • Muscular Dystrophy Association (255856, 422006)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle. https://app.cochat.ai/papers/10.1074/jbc.ra118.007287
The paper
Banerjee, A., Phillips, B. L., Deng, Q., Seyfried, N. T., Pavlath, G. K., Vest, K. E., & Corbett, A. H. (2019). Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.ra118.007287

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.